| Phase III randomized comparison of gemcitabine versus gemcitabine plus capecitabine in patients with advanced pancreatic cancer D Cunningham, I Chau, DD Stocken, JW Valle, D Smith, W Steward, ... Journal of Clinical Oncology 27 (33), 5513-5518, 2009 | 975 | 2009 |
| Preoperative (neoadjuvant) chemoradiotherapy in oesophageal cancer JI Geh, AM Crellin, R Glynne‐Jones British journal of surgery 88 (3), 338-356, 2001 | 248 | 2001 |
| Neoadjuvant cisplatin and fluorouracil versus epirubicin, cisplatin, and capecitabine followed by resection in patients with oesophageal adenocarcinoma (UK MRC OE05): an open … D Alderson, D Cunningham, M Nankivell, JM Blazeby, SM Griffin, ... The lancet oncology 18 (9), 1249-1260, 2017 | 228 | 2017 |
| Interventions for dysphagia in oesophageal cancer A Sreedharan, K Harris, A Crellin, D Forman, SM Everett Cochrane Database of Systematic Reviews, 2009 | 160 | 2009 |
| Short-course radiotherapy, with elective delay prior to surgery, in patients with unresectable rectal cancer who have poor performance status or significant co-morbidity P Hatfield, M Hingorani, G Radhakrishna, R Cooper, A Melcher, A Crellin, ... Radiotherapy and Oncology 92 (2), 210-214, 2009 | 143 | 2009 |
| Trends in postoperative radiotherapy delay and the effect on survival in breast cancer patients treated with conservation surgery JS Mikeljevic, R Haward, C Johnston, A Crellin, D Dodwell, A Jones, ... British journal of cancer 90 (7), 1343-1348, 2004 | 141 | 2004 |
| Non-Hodgkin's lymphoma of the testis AM Crellin, BV Hudson, MH Bennett, S Harland, GV Hudson Radiotherapy and Oncology 27 (2), 99-106, 1993 | 119 | 1993 |
| Neoadjuvant chemotherapy for resectable oesophageal and junctional adenocarcinoma: Results from the UK Medical Research Council randomised OEO5 trial (ISRCTN 01852072). D Alderson, RE Langley, MG Nankivell, JM Blazeby, M Griffin, A Crellin, ... Journal of Clinical Oncology 33 (15_suppl), 4002-4002, 2015 | 107 | 2015 |
| Preoperative radiotherapy combined with 5 days per week capecitabine chemotherapy in locally advanced rectal cancer I Craven, A Crellin, R Cooper, A Melcher, P Byrne, D Sebag-Montefiore British journal of cancer 97 (10), 1333-1337, 2007 | 72 | 2007 |
| Why don't British radiotherapists give single fractions of radiotherapy for bone metastases? AM Crellin, A Marks, EJ Maher Clinical Oncology 1 (2), 63-66, 1989 | 71 | 1989 |
| Wide variation in the use of radiotherapy in the management of surgically treated rectal cancer across the English National Health Service EJA Morris, PJ Finan, K Spencer, I Geh, A Crellin, P Quirke, JD Thomas, ... Clinical Oncology 28 (8), 522-531, 2016 | 65 | 2016 |
| 30 day mortality in adult palliative radiotherapy–A retrospective population based study of 14,972 treatment episodes K Spencer, E Morris, E Dugdale, A Newsham, D Sebag-Montefiore, ... Radiotherapy and Oncology 115 (2), 264-271, 2015 | 57 | 2015 |
| Yttrium-90 transarterial radioembolization for chemotherapy-refractory intrahepatic cholangiocarcinoma: a prospective, observational study J White, G Carolan-Rees, M Dale, HE Patrick, TC See, JK Bell, DM Manas, ... Journal of Vascular and Interventional Radiology 30 (8), 1185-1192, 2019 | 48 | 2019 |
| Weekly 5-fluorouracil and leucovorin: achieving lower toxicity with higher dose-intensity in adjuvant chemotherapy after colorectal cancer resection K Patel, DA Anthoney, AM Crellin, D Sebag-Montefiore, J Messruther, ... Annals of oncology 15 (4), 568-573, 2004 | 39 | 2004 |
| Waiting for radiotherapy D Dodwell, A Crellin BMJ 332 (7533), 107-109, 2006 | 38 | 2006 |
| Clinical outcomes following proton therapy for children with central nervous system tumors referred overseas DJ Indelicato, JA Bradley, ES Sandler, PR Aldana, A Sapp, JE Gains, ... Pediatric blood & cancer 64 (12), e26654, 2017 | 37 | 2017 |
| Position statement on ethics, equipoise and research on charged particle radiation therapy M Sheehan, C Timlin, K Peach, A Binik, W Puthenparampil, M Lodge, ... Journal of medical ethics 40 (8), 572-575, 2014 | 37 | 2014 |
| A rapid and systematic review of the clinical effectiveness and cost-effectiveness of gemcitabine for the treatment of pancreatic cancer. S Ward, E Morris, N Bansback, N Calvert, A Crellin, D Forman, M Larvin, ... Health technology assessment (Winchester, England) 5 (24), 1-70, 2001 | 36 | 2001 |
| Proton beam therapy: perspectives on the National Health Service England clinical service and research programme NG Burnet, RI Mackay, E Smith, AL Chadwick, GA Whitfield, DJ Thomson, ... The British Journal of Radiology 93 (1107), 20190873, 2020 | 35 | 2020 |
| The clinical implications of the collapsed cone planning algorithm C Irvine, A Morgan, A Crellin, A Nisbet, I Beange Clinical oncology 16 (2), 148-154, 2004 | 32 | 2004 |
